|Videos|September 27, 2021

Understanding the Medical Needs Associated With Transgender Health

The Fenway Institute is hosting its upcoming Advancing Excellence in Transgender Health conference. The program will include education on transgender medical care as well as how clinicians and people within this community can interact and the former can understand the latter’s needs when it comes to preventative and acute care.

Boston-based Fenway Health has been a community-based medical care organization focusing on equitable, accessible health care, supportive services, and research and education for 50 years. Fenway focuses on LGBTQIA+ people, BIPOC individuals, and other underserved communities. The organization’s, Fenway Institute, is hosting its 7th annual Advancing Excellence in Transgender Health conference later this week. The virtual meeting is for both providers and members of the transgender community.

The conference is designed to train health care teams in providing responsive and confident gender-affirmative health care, grounded in research evidence and best clinical practices. Clinicians are not trained in medical school to understand the unique health challenges for transgender and gender-diverse patients as well as how to engage in dialogue in conversations about health with these patients, explained Alex Keuroghlian, MD, MPH, director of Education and Training Programs, The Fenway Institute.

“Gender-affirming care is not something that’s part of the standard curriculum typically for members of health care teams…it is not something we learn in our formative training,” Keuroghlian stated.

Keuroghlian has organized the educational program for the conference and says there is a robust schedule of sessions that will include a number of areas related to transgender and gender-diverse health as well as infectious disease-related topics including HIV and pre-exposure prophylaxis (PrEP).

Sessions are led by expert faculty specialized in gender-diverse focused research and patient care. The featured keynote speaker is Rachel Levine, MD, Assistant Secretary for Health at the US Department of Health and Human Services. The preconference is on September 30, and the conference runs October 1 to October 3. For people who are interested in attending, they can register here.

Contagion spoke with Keuroghlian recently about the importance of the upcoming conference, understanding the unique challenges associated with medical care for the transgender community, and offers insights and resources for providers to consider accessing for conversations they may have with their transgender patients.


Related to this article

Cefiderocol Continues to Show Activity Against Resistant Gram-Negative Infections
Shionogi data presented at IDWeek 2026 demonstrated a 76.7% clinical response with cefiderocol in carbapenem-resistant respiratory infections and high in vitro activity against resistant P aeruginosa VAP isolates. Christine Slover, PharmD, vice president, Infectious Diseases US Medical Affairs, Shionogi, offers insights on the data as well as clinical considerations for providers when weighing the antibiotic for patients.
Household Contacts Drive Most Hepatitis B Exposures in Young Children
Karen B. Jacobson, MD, MPH, of Kaiser Permanente Northern California, presented data at IDWeek 2026 showing 58.2% of children younger than five years exposed to active hepatitis B in the home were exposed by someone other than their birth mother, a risk maternal screening alone would miss under the CDC’s revised birth dose recommendation.
Inhaled Amikacin Shows Low Resistance Rates in MAC Lung Disease in ENCORE
In the phase 3b ENCORE trial, adding amikacin liposome inhalation suspension (ALIS) to azithromycin and ethambutol significantly improved culture conversion in newly diagnosed MAC lung disease, while treatment-emergent amikacin (2.2%) and macrolide (1.1%) resistance stayed rare. Kevin Winthrop, MD, provides insights around the study.